Study May be Key to Unlocking a Cure
An article published in the Summer 2009 edition of Multiple Sclerosis Quarterly Report, a joint publication of United Spinal Association (www.UnitedSpinal.org) and the North American Research Committee on Multiple Sclerosis (NARCOMS), highlights the positive initial results of patients who have improving neurologic function after receiving a stem cell transplant, despite no longer taking any MS medications.
The results are reported in a National Institutes of Health (NIH)-sponsored study called HALT-MS to confirm whether high-dose immunosuppression followed by autologous stem cell transplantation will prevent MS attacks in patients who are not responding to available
President Obama lifted restrictions on funding for human embryonic stem cell research this morning and issued a presidential memorandum aimed at insulating scientific decisions across the federal government from political influence.
Obama took care to emphasize that the order would not “open the door” to allow human cloning, which he said is “dangerous, profoundly wrong and has no place in our society, or any society.” But the president said stem cell research has enormous potential to further understanding and treatment of many devastating diseases and conditions. America, he said, should play a leading role in exploring the stem-cell research frontier.
By the time Dr. Spencer Misner had carved away the dead and diseased flesh from Bobby Rice’s right foot last year, little remained other than bones and tendons.
“I couldn’t believe it. It didn’t look real. It looked like something out of a movie,” recalled Rice.
Today, the ankle has almost healed. It looks like Rice had simply scraped it. And Rice’s foot has largely healed, too. Misner credits cutting-edge stem cell treatments for saving Rice’s foot and leg.
Rice, who has diabetes, stepped on a piece of glass last fall and his foot quickly became infected. After trying a home remedy,